HIV TREATMENT
2020
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
Manufacturers of heat-stable LPV/r formulations and all relevant stakeholders involved commit to:
Jointly agree upon and execute next steps to optimize the availability and delivery of these formulations in 2019 including:
-
Timely and regular information sharing (including orders placed and timelines for deliveries)
-
Providing best possible demand forecasts
-
Collaborate on the optimization of limited supply within and among countries and joint prioritization among orders to ensure sustainable supplies to children once initiated
-
Support product uptake at country level
-
Regulatory filings as needed to support scale-up, timely responses to queries raised during the review, and implementation (re-validation as required) of post approval changes at risk during the review period.
-
-